About Retra Life Sciences Private Limited
Data last updated:
Retra Life Sciences Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2019PTC128286. Its GSTIN is 29AAJCR8312G1Z5 (Karnataka).
The company has an authorised share capital of ₹1.4 Cr and a paid-up capital of ₹1.4 Cr. It is led by directors including Shobha Venkatesh and Pinjiwakkam Nandakumar Subramanyam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.19 & 20 3rd Floor 1st Main Road Above Karnataka Bank Byatarayanapura M, Ysore Road, Bengaluru, Karnataka, India – 560026.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.29 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹49.59 Lakh (net margin 11.6%) and EBITDA of ₹78.34 Lakh (EBITDA margin 18.3%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 32% over five years.
The company has about 23 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹50 Lakh and satisfied charges of ₹1.7 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website retralsindia.com.
Company details
Contact details
Retra Life Sciences Private Limited's registered office is in Bengaluru, Karnataka. Its website is retralsindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.19 & 20 3rd Floor 1st Main Road Above Karnataka Bank Byatarayanapura M, Ysore Road, Bengaluru, Karnataka, India – 560026
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Retra Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Retra Life Sciences is professional, scientific and technical activities. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, scientific and technical activities | 74 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Retra Life Sciences Private Limited, buy the company report.
Financials of Retra Life Sciences Private Limited
FY 2025 filings availableRetra Life Sciences Private Limited reported revenue of ₹4.29 Cr (up 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 7% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹78.34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹49.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.3% | ||||
| Net Profit Margin | 11.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Retra Life Sciences Private Limited, buy the company report.
Board of directors of Retra Life Sciences Private Limited
Retra Life Sciences has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shobha Venkatesh | Director | 25 Sep 2019 | 7 Years 1 Months | Current |
| Periganji Radhakrishna Ishwarya | Additional Director | 10 Nov 2022 | 4 Years 0 Months | Current |
| Pinjiwakkam Nandakumar Subramanyam | Director | 25 Sep 2019 | 7 Years 1 Months | Current |
| Mamatha Channabasana Patil | Director | 31 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Retra Life Sciences Private Limited is audited by BALAJI L H & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BALAJI L H & CO | FY 2021 | 015543S |
Shareholding
The shareholding of Retra Life Sciences Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Retra Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Nov 2023 | 100811039 | Axis Bank Limited | ₹50 Lakh | Open | |
| 17 Aug 2021 | 100479586 | Others | ₹1.7 Cr | Satisfied |
To see the full charge records of Retra Life Sciences Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Retra Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Retra Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Retra Life Sciences Private Limited has a workforce of 23 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 23 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Retra Life Sciences Private Limited, buy the company report.
GST
Retra Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAJCR8312G1Z5 | Karnataka | Active | 01 Nov 2019 |
To see the full GST registrations and return filing status of Retra Life Sciences Private Limited, buy the company report.
Recent activity
Retra Life Sciences Private Limited has 7 board changes on record since 2019: 4 appointments and 3 cessations. The latest: Ganiga Srinivasaiah Manjunatha ceased to be Additional Director on 10 Oct 2025.
1 earlier event is in the company report.
Frequently asked questions
Retra Life Sciences is an active private limited company based in Bengaluru, Karnataka, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 September 2019 (7+ years old) and is registered under CIN U24239KA2019PTC128286.
Retra Life Sciences has 4 current directors:
- Shobha Venkatesh - Director
- Periganji Radhakrishna Ishwarya - Additional Director
- Pinjiwakkam Nandakumar Subramanyam - Director
- Mamatha Channabasana Patil - Director
The latest financial statements of Retra Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Retra Life Sciences is 29AAJCR8312G1Z5, registered in Karnataka.
The CIN (Corporate Identification Number) of Retra Life Sciences is U24239KA2019PTC128286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retra Life Sciences was incorporated on 25 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Bangalore.
Ganiga Srinivasaiah Manjunatha ceased to be Additional Director on 10 Oct 2025. Periganji Radhakrishna Ishwarya ceased to be Additional Director on 10 Oct 2025. Periganji Radhakrishna Ishwarya was appointed as Additional Director on 10 Nov 2022. Retra Life Sciences has 7 board changes on record in total.
Retra Life Sciences can be reached through the website retralsindia.com. Its registered office is in Bengaluru, Karnataka, India.
The registered office of Retra Life Sciences is at No.19 & 20 3rd Floor 1st Main Road Above Karnataka Bank Byatarayanapura M, Ysore Road, Bengaluru, Karnataka, India – 560026.
Retra Life Sciences operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
